Minireviews
Copyright ©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Mar 24, 2022; 13(3): 209-218
Published online Mar 24, 2022. doi: 10.5306/wjco.v13.i3.209
Breast cancer in India: Present scenario and the challenges ahead
Ravi Mehrotra, Kavita Yadav
Ravi Mehrotra, Department of Health Research, Ministry of Health and Family Welfare, India Cancer Research Consortium, New Delhi 110001, India
Ravi Mehrotra, CHIP Foundation, Noida 201301, India
Kavita Yadav, Centre of Social Medicine & Community Health, Jawahar Lal Nehru University, New Delhi 110067, India
Author contributions: Both authors (Mehrotra R and Yadav K) contributed equally to all aspects of the paper preparation.
Conflict-of-interest statement: The authors declare no potential conflict of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Ravi Mehrotra, MBBS, MD, PhD, Director, Doctor, Department of Health Research, Ministry of Health and Family Welfare, India Cancer Research Consortium, New Delhi 110001, India. ravi.mehrotra@gov.in
Received: April 9, 2021
Peer-review started: April 9, 2021
First decision: June 7, 2021
Revised: June 17, 2021
Accepted: March 7, 2022
Article in press: March 7, 2022
Published online: March 24, 2022
Processing time: 349 Days and 6.4 Hours
Core Tip

Core Tip: This review highlights the progress that has been made in the field of breast cancer management in India over the past few decades, in terms of addressing the various challenges of breast cancer control including diagnostic methods and treatment options. It also highlights the future of breast cancer control strategies with a focus on the coronavirus disease 2019 situation.